|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02167165 |
|
Date of registration:
|
16/06/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Role of SNP and DIGOXIN Response in Atrial Fibrillation Patients
|
|
Scientific title:
|
Role of Genetic Factors in the Response to Digoxin in the Acute Treatment of Atrial Fibrillation |
|
Date of first enrolment:
|
July 2013 |
|
Target sample size:
|
150 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02167165 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Tunisia
| | | | | | | |
|
Contacts
|
|
Name:
|
Nouira Samir, Professor |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Monastir |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients older than 20 years
- Quick AF (heart rate> 120 bpm) diagnosed by ECG
Exclusion Criteria:
- HR under 120 bpm
- Hemodynamically unstable patients
- Atrio-Ventricular-block (second or third degree)
- Ventricular rhythm disorder
- Acute coronary syndrome
- kidney failure
- Hypokalimia
Age minimum:
20 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Atrial Fibrillation
|
|
Intervention(s)
|
|
Drug: Digoxin Injection
|
|
Primary Outcome(s)
|
|
Correlation between the response to digoxin and the genotypes of the patients
[Time Frame: 24 hours]
|
|
Secondary Outcome(s)
|
|
Rhythm and Rate control
[Time Frame: 24 hours]
|
|
Secondary ID(s)
|
|
AF/DIGOXIN
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|